共 50 条
CoronaVac COVID-19 Vaccine-Induced Anaphylaxis: Clinical Characteristics and Revaccination Outcomes
被引:14
|作者:
Laisuan, Wannada
[1
]
Wongsa, Chamard
[2
]
Chiewchalermsri, Chirawat
[3
]
Thongngarm, Torpong
[2
]
Rerkpattanapipat, Ticha
[1
]
Iamrahong, Pansa
[4
]
Ruangwattanachok, Chulapha
[4
]
Nanthapisal, Sira
[5
]
Sompornrattanaphan, Mongkhon
[2
]
机构:
[1] Mahidol Univ, Ramathibodi Hosp, Dept Med, Div Allergy Immunol & Rheumatol, Bangkok, Thailand
[2] Mahidol Univ, Fac Med, Div Allergy & Clin Immunol, Dept Med,Siriraj Hosp, Bangkok, Thailand
[3] Srinakharinwirot Univ, Dept Med, Panyananthaphikkhu Chonprathan Med Ctr, Nonthaburi, Thailand
[4] Mahidol Univ, Ramathibodi Hosp, Fac Med, Clin Pharm Sect,Pharm Div, Bangkok, Thailand
[5] Thammasat Univ, Dept Pediat, Fac Med, Pathum Thani, Thailand
来源:
关键词:
anaphylaxis;
COVID-19;
vaccine;
drug allergy;
excipient;
vaccine allergy;
skin testing;
IMMUNIZATION;
ALUMINUM;
D O I:
10.2147/JAA.S333098
中图分类号:
R392 [医学免疫学];
学科分类号:
100102 ;
摘要:
Anaphylaxis to CoronaVac, an inactivated vaccine against COVID-19, is extremely rare. We report 12 cases of anaphylaxis after CoronaVac administration, focusing on clinical characteristics and management outcomes. Skin test and graded vaccine challenge were successfully performed in our cases and might be considered if an inactivated vaccine is the only remaining option.
引用
收藏
页码:1209 / 1215
页数:7
相关论文